NPPA computed the Retail Price of Metformin Hydrochloride IP 500 mg (As sustained release) + myo-Inositol IP 600 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/ Sun Pharma Laboratories Ltd. (Marketer)

Nov 23, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on November 14, 2025, issued the Computation of Retail Price of Metformin Hydrochloride IP 500 mg (As sustained release) + myo-Inositol IP 600 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/ Sun Pharma Laboratories Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from March, 2025

• The Retail Price has been computed for Each Film Coated Tablet Containing Metformin Hydrochloride IP 500 mg (As sustained release) + myo-Inositol IP 600 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/ Sun Pharma Laboratories Ltd. (Marketer)

• The Total MAT is 59,04,21,165

[Notification No. 19(4856)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT